Menopause management in patients with a history of breast cancer means weighing symptom burden against oncologic risk. This Q&A session pairs a menopause specialist with a breast medical oncologist to take clinician questions on that decision. Bring a case you’re working through, or a question you haven’t found a clear answer to.

Lisa Larkin, MD, FACP, MSCP, IF, is a board-certified internist who practices in Cincinnati. She founded Concierge Medicine of Cincinnati, a multispecialty practice where she serves as CEO, and she is Founder and CEO of Ms.Medicine and Founder and Executive Director of HERmedicine. She serves on the Board of Trustees of The Menopause Society, where she was President in 2024 and 2023 Scientific Program Chair, and is on the editorial board of the journal Menopause. She is a past board member of the International Society for the Study of Women’s Sexual Health.

Maryam Lustberg, MD, MPH, is Director of the Center for Breast Cancer at Smilow Cancer Hospital and Yale Cancer Center, Chief of Breast Medical Oncology at Yale Cancer Center, and Professor of Medicine (Medical Oncology). She is an NCI-funded investigator active in the Alliance and SWOG cooperative groups, and serves on ASCO’s Patient and Survivor Care Education Committee and Neuropathy Expert Guideline Panel.